These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10462080)

  • 21. Metabolic studies on haloperidol and its tetrahydropyridinyl dehydration product (HPTP) in C57BL/6 mouse brain preparations.
    Usuki E; Bloomquist JR; Freeborn E; Casagnoli K; Van Der Schyf CJ; Castagnoli N
    Neurotox Res; 2002 Feb; 4(1):51-8. PubMed ID: 12826493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies.
    Bloomquist J; King E; Wright A; Mytilineou C; Kimura K; Castagnoli K; Castagnoli N
    J Pharmacol Exp Ther; 1994 Aug; 270(2):822-30. PubMed ID: 8071874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP3A is responsible for N-dealkylation of haloperidol and bromperidol and oxidation of their reduced forms by human liver microsomes.
    Tateishi T; Watanabe M; Kumai T; Tanaka M; Moriya H; Yamaguchi S; Satoh T; Kobayashi S
    Life Sci; 2000 Nov; 67(24):2913-20. PubMed ID: 11133003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.
    Fang J; McKay G; Song J; Remillrd A; Li X; Midha K
    Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma alpha-one acid glycoprotein and haloperidol concentrations in schizophrenic patients.
    Jann MW; Crabtree BL; Pitts WM; Lam YW; Carter JG
    Neuropsychobiology; 1997; 36(1):32-6. PubMed ID: 9211442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma haloperidol and reduced haloperidol concentrations in a geriatric population.
    Chang WH; Jann MW; Chiang TS; Lin HN; Hu WH; Chien CP
    Neuropsychobiology; 1996; 33(1):12-6. PubMed ID: 8821369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haloperidol cytotoxicity and its relation to oxidative stress.
    Raudenska M; Gumulec J; Babula P; Stracina T; Sztalmachova M; Polanska H; Adam V; Kizek R; Novakova M; Masarik M
    Mini Rev Med Chem; 2013 Dec; 13(14):1993-8. PubMed ID: 24160710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of haloperidol in patients on hemodialysis].
    Sanga M; Shigemura J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Apr; 18(2):45-7. PubMed ID: 9656232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant effects of rice bran oil mitigate repeated haloperidol-induced tardive dyskinesia in male rats.
    Samad N; Haleem DJ
    Metab Brain Dis; 2017 Aug; 32(4):1099-1107. PubMed ID: 28374238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P450-catalyzed vs. electrochemical oxidation of haloperidol studied by ultra-performance liquid chromatography/electrospray ionization mass spectrometry.
    Mali'n TJ; Weidolf L; Castagnoli N; Jurva U
    Rapid Commun Mass Spectrom; 2010 May; 24(9):1231-40. PubMed ID: 20391593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats.
    Oda Y; Fujita Y; Oishi K; Nakata Y; Takase M; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
    Psychopharmacology (Berl); 2017 Oct; 234(20):3027-3036. PubMed ID: 28744562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration.
    Kurachi M; Shibata R; Murata M; Tanii Y
    Biol Psychiatry; 1995 Apr; 37(7):487-90. PubMed ID: 7786966
    [No Abstract]   [Full Text] [Related]  

  • 35. On the metabolism of haloperidol.
    Gorrod JW; Fang J
    Xenobiotica; 1993 May; 23(5):495-508. PubMed ID: 8342297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2009 Jan; 91(3):423-9. PubMed ID: 18789960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
    Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
    J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol.
    Umeda Y; Sumi T
    Eur J Pharmacol; 1990 Nov; 191(2):149-55. PubMed ID: 2086236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter.
    Fachinetto R; Villarinho JG; Wagner C; Pereira RP; Avila DS; Burger ME; Calixto JB; Rocha JB; Ferreira J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1478-86. PubMed ID: 17669571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits.
    Metzger KL; Shoemaker JM; Kahn JB; Maxwell CR; Liang Y; Tokarczyk J; Kanes SJ; Hans M; Lowman AM; Dan N; Winey KI; Swerdlow NR; Siegel SJ
    Psychopharmacology (Berl); 2007 Feb; 190(2):201-11. PubMed ID: 17119931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.